ArticlePaediatric drugs2023

Macitentan in the Young-Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center.

Sulaima Albinni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.